The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.

The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.

This study was designed to determine the effects of vandetanib, a small-molecule receptor tyrosine kinase inhibitor of vascular endothelial growth factor and epidermal growth factor receptor, on paclitaxel (PTX) tumor distribution and antitumor activity in xenograft models of human ovarian carcinoma...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Cesca, M, Frapolli, R, Berndt, A, Scarlato, V, Richter, P, Kosmehl, H, D'Incalci, M, Ryan, A, Giavazzi, R
פורמט:	Journal article
שפה:	English
יצא לאור:	2009

פריטים דומים

Hyaluronic Acid- Paclitaxel: Antitumor Efficacy against CD44(+) Human Ovarian Carcinoma Xenografts
מאת: Edmond Auzenne, et al.
יצא לאור: (2007-06-01)

Combination of vandetanib, radiotherapy, and irinotecan in the LoVo human colorectal cancer xenograft model.
מאת: Wachsberger, P, et al.
יצא לאור: (2009)

Determination of paclitaxel distribution in solid tumors by nano-particle assisted laser desorption ionization mass spectrometry imaging.
מאת: Lavinia Morosi, et al.
יצא לאור: (2013-01-01)

Vandetanib inhibits growth of adenoid cystic carcinoma in an orthotopic nude mouse model.
מאת: Choi, S, et al.
יצא לאור: (2008)

Modulation of gene expression associated with copy number variation identifies key regulatory programs in high-grade serous ovarian carcinoma
מאת: Martina Vescio, et al.
יצא לאור: (2023-07-01)

Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma
מאת: Hideki Iwamoto, et al.
יצא לאור: (2011-03-01)

Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in Ovarian Cancer Murine Xenografts
מאת: Demuytere J, et al.
יצא לאור: (2024-01-01)

The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats.
מאת: Cervellini, I, et al.
יצא לאור: (2010)

Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat.
מאת: Tai, J, et al.
יצא לאור: (2010)

Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat
מאת: Tai, J, et al.
יצא לאור: (2010)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
מאת: Nils Degrauwe, et al.
יצא לאור: (2012-06-01)

Selective use of vandetanib in the treatment of thyroid cancer
מאת: Fallahi P, et al.
יצא לאור: (2015-07-01)

Biophysical and computational characterization of vandetanib–lysozyme interaction
מאת: Kabir, Md Zahirul, et al.
יצא לאור: (2018)

Investigating the effect of vandetanib and celecoxib combination on angiogenesis
מאת: Abdul Qadir, MPhil, et al.
יצא לאור: (2023-10-01)

Dermoscopic findings of perifollicular pigmentation associated with vandetanib
מאת: Jade Cury-Martins, et al.
יצא לאור: (2018-10-01)

Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas
מאת: Roberta Affatato, et al.
יצא לאור: (2022-05-01)

Effects of vandetanib on adenoma formation in a dextran sodium sulphate enhanced Apc(MIN/+) mouse model.
מאת: Alferez, D, et al.
יצא לאור: (2010)

A novel compound ARN-3236 inhibits salt-inducible kinase 2 and sensitizes ovarian cancer cell lines and xenografts to paclitaxel.
מאת: Zhou, J, et al.
יצא לאור: (2016)

Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC
מאת: Heymach, J, et al.
יצא לאור: (2008)

Impact of tumor cell VEGF expression on the in vivo efficacy of vandetanib (ZACTIMA; ZD6474).
מאת: Siemann, D, et al.
יצא לאור: (2009)

Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts
מאת: Francesca Ricci, et al.
יצא לאור: (2017-05-01)

Inhibitory effect of luteolin on the metabolism of vandetanib in vivo and in vitro
מאת: Yuxin Shen, et al.
יצא לאור: (2025-03-01)

Effect of Vandetanib Treatment on Cystic Changes in the Liver following Metastasis from Medullary Thyroid Carcinoma
מאת: Ai Matsui, et al.
יצא לאור: (2022-01-01)

Driving p53 Response to Bax Activation Greatly Enhances Sensitivity to Taxol by Inducing Massive Apoptosis
מאת: Paola De Feudis, et al.
יצא לאור: (2000-05-01)

Establishment and characterization of ovarian clear cell carcinoma patient-derived xenografts
מאת: Joseph J. Caumanns, et al.
יצא לאור: (2025-02-01)

N-Acetylcysteine Augments Surface Thiols and Differentially Modulates Cell Adhesion and Invasion in vitro and Metastatic Potential in vivo of B16F1 Melanoma
מאת: T. Laragione, et al.
יצא לאור: (2005-01-01)

Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
מאת: Fallahi P, et al.
יצא לאור: (2019-08-01)

Nitric oxide synthase inhibition enhances the antitumor effect of radiation in the treatment of squamous carcinoma xenografts.
מאת: Robert J G Cardnell, et al.
יצא לאור: (2011-01-01)

Vandetanib induced phototoxic reaction progressed to toxic epidermal necrolysis
מאת: Busra Demirbag Gul, et al.
יצא לאור: (2022-02-01)

Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment
מאת: Carlos M. Galmarini, et al.
יצא לאור: (2014-01-01)

Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives
מאת: Alberto Zambelli, et al.
יצא לאור: (2023-01-01)

Antitumor action of an aminochromene derivative on human - derived lung adenocarcinoma xenograft model
מאת: E. A. Samishina, et al.
יצא לאור: (2019-06-01)

LAMININ-5. A POTENTIAL TOOL IN DIAGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA
מאת: Hartwig Kosmehl, et al.
יצא לאור: (2002-12-01)

Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply
מאת: Jr, W, et al.
יצא לאור: (2012)

Transportan in nanocarriers improves skin localization and antitumor activity of paclitaxel
מאת: Pepe D, et al.
יצא לאור: (2016-05-01)

Colony-stimulating factor-1 receptor inhibition combined with paclitaxel exerts effective antitumor effects in the treatment of ovarian cancer
מאת: Meijia Yu, et al.
יצא לאור: (2024-05-01)

BRCA1 foci test as a predictive biomarker of olaparib response in ovarian cancer patient-derived xenograft models
מאת: Federica Guffanti, et al.
יצא לאור: (2024-06-01)

Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts
מאת: Kumar, K, et al.
יצא לאור: (2013)

Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts.
מאת: Kumar, K, et al.
יצא לאור: (2013)

Vandetanib as a prospective anti-inflammatory and anti-contractile agent in asthma
מאת: Xiaoyue Zeng, et al.
יצא לאור: (2024-05-01)